The global Liposomal Drug Delivery Device market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Liposomal Drug Delivery Device companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug Delivery Device. This report contains market size and forecasts of Liposomal Drug Delivery Device in global, including the following market information:
Global Liposomal Drug Delivery Device market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Liposomal Drug Delivery Device companies in 2024 (%)
Total Market by Segment:
Global Liposomal Drug Delivery Device market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Liposomal Drug Delivery Device market segment percentages, by Type, 2024 (%)
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Global Liposomal Drug Delivery Device market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Liposomal Drug Delivery Device market segment percentages, by Application, 2024 (%)
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
Global Liposomal Drug Delivery Device market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Liposomal Drug Delivery Device market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Drug Delivery Device revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Liposomal Drug Delivery Device revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomal Drug Delivery Device, market overview.
Chapter 2: Global Liposomal Drug Delivery Device market size in revenue.
Chapter 3: Detailed analysis of Liposomal Drug Delivery Device company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomal Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomal Drug Delivery Device Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Liposomal Drug Delivery Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomal Drug Delivery Device Overall Market Size
2.1 Global Liposomal Drug Delivery Device Market Size: 2024 VS 2032
2.2 Global Liposomal Drug Delivery Device Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomal Drug Delivery Device Players in Global Market
3.2 Top Global Liposomal Drug Delivery Device Companies Ranked by Revenue
3.3 Global Liposomal Drug Delivery Device Revenue by Companies
3.4 Top 3 and Top 5 Liposomal Drug Delivery Device Companies in Global Market, by Revenue in 2024
3.5 Global Companies Liposomal Drug Delivery Device Product Type
3.6 Tier 1, Tier 2, and Tier 3 Liposomal Drug Delivery Device Players in Global Market
3.6.1 List of Global Tier 1 Liposomal Drug Delivery Device Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomal Drug Delivery Device Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Liposomal Drug Delivery Device Market Size Markets, 2024 & 2032
4.1.2 Stealth Liposome Technology
4.1.3 NonPEGylated Liposome Technology
4.1.4 DepoFoam Liposome Technology
4.2 Segmentation by Type - Global Liposomal Drug Delivery Device Revenue & Forecasts
4.2.1 Segmentation by Type - Global Liposomal Drug Delivery Device Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Liposomal Drug Delivery Device Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Liposomal Drug Delivery Device Market Size, 2024 & 2032
5.1.2 Fungal Diseases
5.1.3 Cancer Therapy
5.1.4 Pain Management
5.1.5 Viral Vaccines
5.1.6 Photodynamic Therapy
5.2 Segmentation by Application - Global Liposomal Drug Delivery Device Revenue & Forecasts
5.2.1 Segmentation by Application - Global Liposomal Drug Delivery Device Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Liposomal Drug Delivery Device Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Liposomal Drug Delivery Device Market Size, 2024 & 2032
6.2 By Region - Global Liposomal Drug Delivery Device Revenue & Forecasts
6.2.1 By Region - Global Liposomal Drug Delivery Device Revenue, 2020-2025
6.2.2 By Region - Global Liposomal Drug Delivery Device Revenue, 2026-2032
6.2.3 By Region - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Liposomal Drug Delivery Device Revenue, 2020-2032
6.3.2 United States Liposomal Drug Delivery Device Market Size, 2020-2032
6.3.3 Canada Liposomal Drug Delivery Device Market Size, 2020-2032
6.3.4 Mexico Liposomal Drug Delivery Device Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Liposomal Drug Delivery Device Revenue, 2020-2032
6.4.2 Germany Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.3 France Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.4 U.K. Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.5 Italy Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.6 Russia Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.7 Nordic Countries Liposomal Drug Delivery Device Market Size, 2020-2032
6.4.8 Benelux Liposomal Drug Delivery Device Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Liposomal Drug Delivery Device Revenue, 2020-2032
6.5.2 China Liposomal Drug Delivery Device Market Size, 2020-2032
6.5.3 Japan Liposomal Drug Delivery Device Market Size, 2020-2032
6.5.4 South Korea Liposomal Drug Delivery Device Market Size, 2020-2032
6.5.5 Southeast Asia Liposomal Drug Delivery Device Market Size, 2020-2032
6.5.6 India Liposomal Drug Delivery Device Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Liposomal Drug Delivery Device Revenue, 2020-2032
6.6.2 Brazil Liposomal Drug Delivery Device Market Size, 2020-2032
6.6.3 Argentina Liposomal Drug Delivery Device Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, 2020-2032
6.7.2 Turkey Liposomal Drug Delivery Device Market Size, 2020-2032
6.7.3 Israel Liposomal Drug Delivery Device Market Size, 2020-2032
6.7.4 Saudi Arabia Liposomal Drug Delivery Device Market Size, 2020-2032
6.7.5 UAE Liposomal Drug Delivery Device Market Size, 2020-2032
7 Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Liposomal Drug Delivery Device Major Product Offerings
7.1.4 Novartis AG Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Luye Pharma Group
7.2.1 Luye Pharma Group Corporate Summary
7.2.2 Luye Pharma Group Business Overview
7.2.3 Luye Pharma Group Liposomal Drug Delivery Device Major Product Offerings
7.2.4 Luye Pharma Group Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.2.5 Luye Pharma Group Key News & Latest Developments
7.3 Ipsen Pharma
7.3.1 Ipsen Pharma Corporate Summary
7.3.2 Ipsen Pharma Business Overview
7.3.3 Ipsen Pharma Liposomal Drug Delivery Device Major Product Offerings
7.3.4 Ipsen Pharma Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.3.5 Ipsen Pharma Key News & Latest Developments
7.4 Celsion, Inc.
7.4.1 Celsion, Inc. Corporate Summary
7.4.2 Celsion, Inc. Business Overview
7.4.3 Celsion, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.4.4 Celsion, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.4.5 Celsion, Inc. Key News & Latest Developments
7.5 Galen Limited
7.5.1 Galen Limited Corporate Summary
7.5.2 Galen Limited Business Overview
7.5.3 Galen Limited Liposomal Drug Delivery Device Major Product Offerings
7.5.4 Galen Limited Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.5.5 Galen Limited Key News & Latest Developments
7.6 Astellas Pharma, Inc.
7.6.1 Astellas Pharma, Inc. Corporate Summary
7.6.2 Astellas Pharma, Inc. Business Overview
7.6.3 Astellas Pharma, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.6.4 Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.6.5 Astellas Pharma, Inc. Key News & Latest Developments
7.7 Acrotech Biopharma, Inc.
7.7.1 Acrotech Biopharma, Inc. Corporate Summary
7.7.2 Acrotech Biopharma, Inc. Business Overview
7.7.3 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.7.4 Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.7.5 Acrotech Biopharma, Inc. Key News & Latest Developments
7.8 Fudan-Zhangjiang
7.8.1 Fudan-Zhangjiang Corporate Summary
7.8.2 Fudan-Zhangjiang Business Overview
7.8.3 Fudan-Zhangjiang Liposomal Drug Delivery Device Major Product Offerings
7.8.4 Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.8.5 Fudan-Zhangjiang Key News & Latest Developments
7.9 Pacira
7.9.1 Pacira Corporate Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Liposomal Drug Delivery Device Major Product Offerings
7.9.4 Pacira Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.9.5 Pacira Key News & Latest Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Corporate Summary
7.10.2 Creative Biolabs Business Overview
7.10.3 Creative Biolabs Liposomal Drug Delivery Device Major Product Offerings
7.10.4 Creative Biolabs Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.10.5 Creative Biolabs Key News & Latest Developments
7.11 Precision NanoSystems Inc.
7.11.1 Precision NanoSystems Inc. Corporate Summary
7.11.2 Precision NanoSystems Inc. Business Overview
7.11.3 Precision NanoSystems Inc. Liposomal Drug Delivery Device Major Product Offerings
7.11.4 Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.11.5 Precision NanoSystems Inc. Key News & Latest Developments
7.12 Encapsula NanoSciences LLC
7.12.1 Encapsula NanoSciences LLC Corporate Summary
7.12.2 Encapsula NanoSciences LLC Business Overview
7.12.3 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Major Product Offerings
7.12.4 Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.12.5 Encapsula NanoSciences LLC Key News & Latest Developments
7.13 Avanti Polar Lipids, Inc.
7.13.1 Avanti Polar Lipids, Inc. Corporate Summary
7.13.2 Avanti Polar Lipids, Inc. Business Overview
7.13.3 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Major Product Offerings
7.13.4 Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.13.5 Avanti Polar Lipids, Inc. Key News & Latest Developments
7.14 Viatris Inc.
7.14.1 Viatris Inc. Corporate Summary
7.14.2 Viatris Inc. Business Overview
7.14.3 Viatris Inc. Liposomal Drug Delivery Device Major Product Offerings
7.14.4 Viatris Inc. Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.14.5 Viatris Inc. Key News & Latest Developments
7.15 Merrimack Pharmaceuticals, Inc
7.15.1 Merrimack Pharmaceuticals, Inc Corporate Summary
7.15.2 Merrimack Pharmaceuticals, Inc Business Overview
7.15.3 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Major Product Offerings
7.15.4 Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue in Global Market (2020-2025)
7.15.5 Merrimack Pharmaceuticals, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Liposomal Drug Delivery Device Market Opportunities & Trends in Global Market
Table 2. Liposomal Drug Delivery Device Market Drivers in Global Market
Table 3. Liposomal Drug Delivery Device Market Restraints in Global Market
Table 4. Key Players of Liposomal Drug Delivery Device in Global Market
Table 5. Top Liposomal Drug Delivery Device Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Liposomal Drug Delivery Device Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Liposomal Drug Delivery Device Revenue Share by Companies, 2020-2025
Table 8. Global Companies Liposomal Drug Delivery Device Product Type
Table 9. List of Global Tier 1 Liposomal Drug Delivery Device Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomal Drug Delivery Device Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Liposomal Drug Delivery Device Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Liposomal Drug Delivery Device Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue, (US$, Mn), 2026-2032
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Liposomal Drug Delivery Device Product Offerings
Table 32. Novartis AG Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Luye Pharma Group Corporate Summary
Table 35. Luye Pharma Group Liposomal Drug Delivery Device Product Offerings
Table 36. Luye Pharma Group Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 37. Luye Pharma Group Key News & Latest Developments
Table 38. Ipsen Pharma Corporate Summary
Table 39. Ipsen Pharma Liposomal Drug Delivery Device Product Offerings
Table 40. Ipsen Pharma Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 41. Ipsen Pharma Key News & Latest Developments
Table 42. Celsion, Inc. Corporate Summary
Table 43. Celsion, Inc. Liposomal Drug Delivery Device Product Offerings
Table 44. Celsion, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 45. Celsion, Inc. Key News & Latest Developments
Table 46. Galen Limited Corporate Summary
Table 47. Galen Limited Liposomal Drug Delivery Device Product Offerings
Table 48. Galen Limited Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 49. Galen Limited Key News & Latest Developments
Table 50. Astellas Pharma, Inc. Corporate Summary
Table 51. Astellas Pharma, Inc. Liposomal Drug Delivery Device Product Offerings
Table 52. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 53. Astellas Pharma, Inc. Key News & Latest Developments
Table 54. Acrotech Biopharma, Inc. Corporate Summary
Table 55. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Product Offerings
Table 56. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 57. Acrotech Biopharma, Inc. Key News & Latest Developments
Table 58. Fudan-Zhangjiang Corporate Summary
Table 59. Fudan-Zhangjiang Liposomal Drug Delivery Device Product Offerings
Table 60. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 61. Fudan-Zhangjiang Key News & Latest Developments
Table 62. Pacira Corporate Summary
Table 63. Pacira Liposomal Drug Delivery Device Product Offerings
Table 64. Pacira Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 65. Pacira Key News & Latest Developments
Table 66. Creative Biolabs Corporate Summary
Table 67. Creative Biolabs Liposomal Drug Delivery Device Product Offerings
Table 68. Creative Biolabs Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 69. Creative Biolabs Key News & Latest Developments
Table 70. Precision NanoSystems Inc. Corporate Summary
Table 71. Precision NanoSystems Inc. Liposomal Drug Delivery Device Product Offerings
Table 72. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 73. Precision NanoSystems Inc. Key News & Latest Developments
Table 74. Encapsula NanoSciences LLC Corporate Summary
Table 75. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Product Offerings
Table 76. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 77. Encapsula NanoSciences LLC Key News & Latest Developments
Table 78. Avanti Polar Lipids, Inc. Corporate Summary
Table 79. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Product Offerings
Table 80. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 81. Avanti Polar Lipids, Inc. Key News & Latest Developments
Table 82. Viatris Inc. Corporate Summary
Table 83. Viatris Inc. Liposomal Drug Delivery Device Product Offerings
Table 84. Viatris Inc. Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 85. Viatris Inc. Key News & Latest Developments
Table 86. Merrimack Pharmaceuticals, Inc Corporate Summary
Table 87. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Product Offerings
Table 88. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue (US$, Mn) & (2020-2025)
Table 89. Merrimack Pharmaceuticals, Inc Key News & Latest Developments
List of Figures
Figure 1. Liposomal Drug Delivery Device Product Picture
Figure 2. Liposomal Drug Delivery Device Segment by Type in 2024
Figure 3. Liposomal Drug Delivery Device Segment by Application in 2024
Figure 4. Global Liposomal Drug Delivery Device Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Liposomal Drug Delivery Device Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Liposomal Drug Delivery Device Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Liposomal Drug Delivery Device Revenue in 2024
Figure 9. Segmentation by Type � Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Liposomal Drug Delivery Device Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 13. By Region - Global Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 14. By Country - North America Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 15. United States Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 19. Germany Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 20. France Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 27. China Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 31. India Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 33. Brazil Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Liposomal Drug Delivery Device Revenue Market Share, 2020-2032
Figure 36. Turkey Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Liposomal Drug Delivery Device Revenue, (US$, Mn), 2020-2032
Figure 40. Novartis AG Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Luye Pharma Group Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Ipsen Pharma Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Celsion, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Galen Limited Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Astellas Pharma, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Acrotech Biopharma, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Fudan-Zhangjiang Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Pacira Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Creative Biolabs Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Precision NanoSystems Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Encapsula NanoSciences LLC Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Avanti Polar Lipids, Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Viatris Inc. Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Merrimack Pharmaceuticals, Inc Liposomal Drug Delivery Device Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
